Morgan Stanley reiterates Overweight on Sherwin-Williams stock

NodeGuardian · 2026-03-26T03:16:52+00:00

Morgan Stanley maintains an Overweight rating on Sherwin-Williams, targeting $385, citing strong earnings, pricing power, and dividend growth. Q4 2025 results exceeded expectations, with EPS of $2.23 and revenue of $5.6 billion, demonstrating market share growth.

NodeGuardian

2026-03-26 03:16:52

Abstract generation in progress

Morgan Stanley has reiterated an Overweight rating on Sherwin-Williams Co. with a price target of $385.00, despite the stock trading near its 52-week low and InvestingPro suggesting it may be overvalued. The firm maintains a positive outlook on the company due to strong earnings power, best-in-class pricing power, and consistent dividend increases, noting accelerating market share growth and conservative future guidance. Recent financial results for Q4 2025 showed Sherwin-Williams surpassed analyst expectations with EPS of $2.23 and revenue of $5.6 billion, and the company extended a $75 million credit agreement to boost financial flexibility.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.